Abstract
The evaluation and treatment of acute multiple sclerosis (MS) relapses has several aspects.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Miller D, Weinstock-Guttman B, Bethoux F, et al. A meta-analysis of methylprednisolone in recovery from multiple sclerosis exacerbations. Mult Scler. 2000;6:267-273.
Weinshenker BG, O’Brien P, Petterson TM, et al. A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol.1999;46:878-886.
Fox RJ, Kinkel RP. High-dose methylprednisolone in the treatment of multiple sclerosis. In: Cohen JA, Rudick RA, eds. Multiple Sclerosis Therapeutics, 3rd edition. London, UK: Informa Healthcare; 2007:515-533.
Cohen JA, Imrey PB, Calabresi PA, et al. Results of the Avonex Combination Trial (ACT) in relapsing–remitting MS. Neurology. 2009;72:535-541.
Beck RW, Cleary PA, Anderson MM, et al. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. N Engl J Med. 1992;326:581-588.
Robson LS, Bain C, Beck S, et al. Cost analysis of methylprednisolone treatment of multiple sclerosis patients. Can J Neurol Sci. 1998;25:222-229.
Morrow SA, Stoian CA, Dmitrovic J, et al. The bioavailability of IV methylprednisolone and oral prednisone in multiple sclerosis. Neurology. 2004;63:1079-1080.
Metz LM, Sabuda D, Hilsden RJ, et al. Gastric tolerance of high-dose pulse oral prednisone n multiple sclerosis. Neurology. 1999;53:2093-2096.
Ratto D, Alfaro C, Sipsey J, et al. Are intravenous corticosteroids required in status asthmaticus? JAMA. 1988;260:527-529.
Smith MD, Ahern MJ, Roberts-Thomson PJ. Pulse steroid therapy in rheumatoid arthritis: can equivalent doses of oral prednisolone give similar clinical results to intravenous methylprednisolone? Ann Rheum Dis. 1988;47:28-33.
Alam SM, Kyriakides T, Lawden M, et al. Methylprednisolone in multiple sclerosis: a comparison of oral with intravenous therapy at equivalent high dose. J Neurol Neurosurg Psychiatry. 1993;56:1219-1220.
Barnes D, Hughes RAC, Morris RW, et al. Randomised trial of oral and intravenous methylprednisolone in acute relapses of multiple sclerosis. Lancet. 1997;349:902-906.
Sellebjerg F, Frederiksen JL, Nielsen PM, et al. Double-blind, randomized, placebo-controlled study of oral, high-dose methylprednisolone in attacks of MS. Neurology. 1998;51:529-534.
Sellebjerg F, Nielsen SH, Fredericksen JL, et al. A randomized, controlled trial of oral high-dose methylprednisolone in acute optic neuritis. Neurology. 1999;52:1479-1484.
Martinelli V, Rocca MA, Annovazzi P, et al. A short-term randomized MRI study of high-dose oral vs intravenous methylprednisolone in MS. Neurology. 2009;73:1842-1848.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2012 Springher Healthcare
About this chapter
Cite this chapter
Cohen, J.A., Rae-Grant, A. (2012). Treatment of Acute Relapses of Multiple Sclerosis. In: Handbook of Multiple Sclerosis. Springer Healthcare, Tarporley. https://doi.org/10.1007/978-1-907673-50-4_4
Download citation
DOI: https://doi.org/10.1007/978-1-907673-50-4_4
Published:
Publisher Name: Springer Healthcare, Tarporley
Print ISBN: 978-1-908517-49-4
Online ISBN: 978-1-907673-50-4
eBook Packages: MedicineMedicine (R0)